Chen P, Li C, Lang S, Zhu G, Reheman A, Spring CM, et al
Magnus Aronson Varnar fr produkten Lkemedelsverket varnar fr produkten eftersom det inte r ett godknt lkemedel
Sweating is not listed as a common adverse effect in official prescribing information for GLP-1 medications including semaglutide, dulaglutide, and liraglutide
Cohort studies across Mediterranean regions generally report that MD patterns are associated with lower rates of depression and cognitive decline, conditions highly relevant to thyroid populations (205207)
In addition, GLP-1R is moderately in the lung, heart, kidney, blood vessels, pancreatic alpha cells, and peripheral nervous system, with no expression of GLP-1R in liver, skeletal muscle or adipose tissue (109112)
Beyond established players, new entrants are joining the race